Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medesis Pharma SA

ALMDP
Current price
0.72 EUR -0.036 EUR (-4.75%)
Last closed 0.76 EUR
ISIN FR0010844464
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 5 046 436 EUR
Yield for 12 month -41.30 %
1Y
3Y
5Y
10Y
15Y
ALMDP
21.11.2021 - 28.11.2021

Medesis Pharma S.A. operates as a biopharmaceutical company. The company's products include NanoLithium (NP03) for the treatment of Alzheimer's disease; NanosiRNA HD and NanoP42T to treat Huntington's disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France. Address: L?Orée des Mas, Montpellier, France, 34670

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.98 EUR

P/E ratio

Dividend Yield

Current Year

+299 248 EUR

Last Year

+47 173 EUR

Current Quarter

+133 424 EUR

Last Quarter

+133 424 EUR

Current Year

-2 657 788 EUR

Last Year

-2 199 324 EUR

Current Quarter

-469 609 EUR

Last Quarter

-469 609 EUR

Key Figures ALMDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 923 051 EUR
Operating Margin TTM -7852.13 %
PE Ratio
Return On Assets TTM -137.6 %
PEG Ratio
Return On Equity TTM -934.59 %
Wall Street Target Price 2.98 EUR
Revenue TTM 299 248 EUR
Book Value -0.9 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -79.9 %
Dividend Yield
Gross Profit TTM -2 049 717 EUR
Earnings per share -0.8 EUR
Diluted Eps TTM -0.8 EUR
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALMDP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALMDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALMDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 20.724
Price Sales TTM 16.8637
Enterprise Value EBITDA -3.5631
Price Book MRQ 108.2311

Financials ALMDP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALMDP

For 52 weeks

0.7 EUR 2.39 EUR
50 Day MA 0.84 EUR
Shares Short Prior Month
200 Day MA 1.01 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

T

TTNP

5.73 USD Titan Pharmaceuticals Inc -0.21 (-3.53%)
Detailed analytics
O

ORMNF

0.18 USD Orex Minerals Inc 0 (0%)
Detailed analytics
8

8239

0.47 HKD Capital Finance Holdings Ltd 0 (0%)
Detailed analytics
7

76D

0.68 EUR MEDESIS PHARMA SA EO 2- 0 (0%)
Detailed analytics
1

1D3

0.0030 SGD LIFEBRANDZ LTD. -0 (-0%)
Detailed analytics